Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

90.87
+0.37000.41%
Post-market: 90.80-0.0700-0.08%18:40 EDT
Volume:2.39M
Turnover:216.76M
Market Cap:52.39B
PE:52.86
High:91.27
Open:90.38
Low:89.68
Close:90.50
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:0.83
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.93
PE(LYR):49.58

Loading ...

How Stronger 2026 Sales Outlook And Q2 Results At Edwards Lifesciences (EW) Have Changed Its Investment Story

Simply Wall St.
·
Jul 29

UBS Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $110 From $90

MT Newswires Live
·
Jul 28

Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Edwards Lifesciences (EW)

TIPRANKS
·
Jul 28

Top Executive Cashes In on Major Edwards Lifesciences Stock Move

TIPRANKS
·
Jul 28

Edwards Lifesciences CEO Bernard J. Zovighian Disposes of 2,920 Shares for $245,082.66

Reuters
·
Jul 28

Rothschild & Co Redburn Adjusts Edwards Lifesciences Price Target to $102 From $99, Maintains Buy Rating

MT Newswires Live
·
Jul 27

Edwards Lifesciences Lifts Outlook On TAVR And TMTT

TIPRANKS
·
Jul 25

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Edwards Lifesciences Price Target Raised to $101.00/share from $100.00 by Piper Sandler

Dow Jones
·
Jul 25

Edwards Lifesciences Seen Building on Catalyst Pipeline, RBC Says

MT Newswires Live
·
Jul 24

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Benzinga Earnings
·
Jul 24

Movement Alert|Edwards Lifesciences Rises 6.05% in Regular Trading, Q2 Earnings Beat Expectations and TAVR Guidance Raised

Market Focus
·
Jul 24

Edwards Lifesciences price target raised to $101 from $100 at Piper Sandler

TIPRANKS
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and GE Healthcare Technologies Inc (GEHC)

TIPRANKS
·
Jul 24

Leerink Partners Upgrades Edwards Lifesciences to Outperform From Market Perform, Adjusts PT to $101 From $87

MT Newswires Live
·
Jul 24

Edwards Lifesciences upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
Jul 24

Edwards Lifesciences Corp : Leerink Partners Raises to Outperform from Market Perform; Raises Target Price to $101 from $87

THOMSON REUTERS
·
Jul 24

Edwards Lifesciences Holding Lifts Carvolix Stake to 11.65% of Capital, 9.07% Voting Rights

Reuters
·
Jul 24

Movement Alert|Edwards Lifesciences Overnight Rise 5.57%, Q2 Earnings Beat Expectations With TAVR Growth Guidance Raised

Market Focus
·
Jul 24

U.S. Research Roundup-deckers Brands, Rollins, United Rentals

Reuters
·
Jul 24